Johnson & Johnson To Reveal Average Drug Price Increases

Associated Press -- Johnson & Johnson plans next month to disclose average price increases of its prescription drugs, as the industry tries to calm the storm over soaring prices. The health care giant will divulge its 2016 average increases in list price and net price, or what middlemen such as insurers and distributors pay J&J after discounts and rebates. Analysts say that will help J&J's image more than patients initially, but could push other drug makers to tame future price increases and be more transparent. "We hope that can create a better understanding of the industry and...ultimately improve patient access to medicines," Joaquin Duato, head of J&J's prescription drug business, said in an interview Tuesday. With annual price tags topping $100,000 for many new drugs for cancer and rare disease, some patients have been unable to afford their medicines. Huge price hikes on old products with little competition, like Mylan's EpiPen emergency allergy injectors, also have left some patients scrambling. To get more details on Johnson & Johnson to reveal average drug price increases click on the pictures below to read the articles.